Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII.

Recio-López P, Valladolid-Acebes I, Hadwiger P, Hossbach M, Krampert M, Prata C, Berggren PO, Juntti-Berggren L

Open source

DOI
10.1002/biof.1885
Published
2023 Jan
Container
BioFactors (Oxford, England)
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/biof.1885,
  title = {Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII.},
  author = {Recio-López P and Valladolid-Acebes I and Hadwiger P and Hossbach M and Krampert M and Prata C and Berggren PO and Juntti-Berggren L},
  year = {2023},
  journal = {BioFactors (Oxford, England)},
  doi = {10.1002/biof.1885},
  url = {https://doi.org/10.1002/biof.1885}
}

RIS

TY  - JOUR
TI  - Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII.
AU  - Recio-López P
AU  - Valladolid-Acebes I
AU  - Hadwiger P
AU  - Hossbach M
AU  - Krampert M
AU  - Prata C
AU  - Berggren PO
AU  - Juntti-Berggren L
PY  - 2023
JO  - BioFactors (Oxford, England)
DO  - 10.1002/biof.1885
UR  - https://doi.org/10.1002/biof.1885
ER  - 

APA

P, R., I, V., P, H., M, H., M, K., C, P., PO, B., & L, J. (2023). Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII.. BioFactors (Oxford, England). https://doi.org/10.1002/biof.1885

Source records